（文章来源：证券日报） 证券日报网讯晶盛机电10月28日发布公告，在公司回答调研者提问时表示，公司积极布局碳化硅产能， 在上虞布局年产30万片碳化硅衬底项目；并基于全球碳化硅产业的良好发展前景和广阔市场，在马来西 亚槟城投建8英寸碳化硅衬底产业化项目，进一步强化公司在全球市场的供应能力；同时，在银川投建 年产60万片8英寸碳化硅衬底片配套晶体项目，不断强化公司在碳化硅衬底材料领域的技术和规模优 势。 ...

安集科技公告，第三季度营收为6.71亿元，同比增长30.24%；净利润为2.33亿元，同比增长46.74%。前 三季度营收为18.12亿元，同比增长38.09%；净利润为6.08亿元，同比增长54.96%。 ...

2025年10月28日，西安奕斯伟材料科技股份有限公司（以下简称"西安奕材"）科创板挂牌， 开盘 大涨461%，市值最高达1600亿。 作为"科八条"发布后首家过会并上市的未盈利企业，其成功上 市将直接推动12寸硅片国产化率突破20%，助力我国半导体产业链提升整体竞争力；同时在资本市 场上，为其他处于高速发展的科技企业提供了示范。 西安奕材的成功上市，在现阶段意义非凡，这是多方共同努力的结果，其中资本在其发展过程中起 到了重要作用。作为最早的投资方之一，孙达飞及其投资团队（三行资本与众行资本投资团队）自 2019年初投资奕斯伟科技，到后期硅材料板块在西安落地并成长为国内12英寸硅片龙头，这段历 程不仅是一家半导体企业的国产突围史，更是三行&众行团队聚焦、深耕产业的投资打法的生动实 践。 道远且阻，但行则必至 在半导体产业的宏大版图中，12寸硅片是芯片制造的关键基底，但长期被五大国际巨头垄断，其 占比高达92%。不再受制于人的决心，让16年底成立的奕斯伟科技一年后正式启动了硅晶圆项目。 彼时，下游需求正在发生结构性爆发：3D NAND存储因智能手机容量升级与数据中心建设的需 求，带动了12英寸硅片广泛和持续性的 ...

公开资料显示，鼎龙股份是国内领先的影像信息材料与电子化学品企业，产品涵盖光刻胶、显影液、抗蚀剂及半导体用关键材料。公司在半导体化学材料领 域的布局正在逐步完善，正形成从研发、验证到量产的完整闭环。 业内人士认为，鼎龙股份在晶圆光刻胶领域的持续突破，标志着国产替代进程进一步提速。随着ArF及更高端制程产品逐步验证，公司有望在国内半导体材 料市场中占据更大份额。（校对/秋贤） 针对投资者关注的技术节点问题，公司表示，其KrF/ArF光刻胶产品正在从成熟制程不断向更先进制程拓展。目前产品覆盖多个核心制程节点，并在部分客 户验证中表现出良好性能。 鼎龙股份指出，公司积极推进国产高端光刻胶的产业化布局，重点突破关键材料的稳定性与适配性问题，致力于为国内晶圆制造厂提供高品质替代方案。公 司光刻胶产品已进入多家客户供应链验证阶段，部分产品预计在后续季度实现量产导入。 （文/罗叶馨梅）10月27日，鼎龙股份(300054.SZ)在投资者互动平台表示，公司在晶圆光刻胶领域持续加大研发投入，已布局近30款高端晶圆光刻胶产品， 其中超过15款已送样客户验证，超过10款进入加仑样测试阶段，整体测试进展顺利。 ...

Core Viewpoint - Companies often pursue cross-industry strategies as a shortcut for market value management, especially when their main business growth peaks. However, many of these attempts result in minimal impact and eventual withdrawal from the market, while a few succeed due to strategic foresight and strong execution capabilities [3][4]. Group 1 - The capital market sees cross-industry layouts as a means to boost market value when core business growth stagnates [3]. - Many companies that attempt cross-industry ventures fail to deliver substantial results, leading to their exit from the market [3]. - Successful cross-industry companies are rare and are characterized by their strategic vision and execution strength, making them worthy of attention [3][4]. Group 2 - A traditional consumable manufacturer has recently transformed into a significant player in the domestic semiconductor materials market, focusing on import substitution [4].

2025 年 10 月 28 日 行业研究/行业周报 新材料 新材料周报（251020-1024） 领先大市-B(维持) 《风能北京宣言 2.0》发布，建议关注风电材料发展机遇 执业登记编码：S0760523120002 邮箱：jiyongjie@sxzq.com 王锐 执业登记编码：S0760524090001 资料来源：最闻 相关报告： 透，建议关注 AI 新材料机遇-新材料周 报（251013-1017） 2025.10.21 稳增长工作方案》，关注汽车上游新材 料机遇-新材料周报（250908-0912） 2025.9.17 冀泳洁 博士 【山证新材料】生成式人工智能快速渗 【山证新材料】八部门印发《汽车行业 可降解材料：PLA(FY201 注塑级)(17800 元/吨，不变)、PLA(REVODE 201 吹膜级)(17000 元/吨，不变)、PBS(17800 元/吨，不变)、PBAT(9850 元/吨，不变) 维生素：维生素 A(62000 元/吨，0.81%)、维生素 E(47500 元/吨，11.76%)、 维生素 D3(212500 元/吨，不变)、泛酸钙(41500 元/吨，不变)、肌醇 ...

Core Viewpoint - Xi'an Yiswei Material Technology Co., Ltd. has successfully listed on the Sci-Tech Innovation Board, becoming the first unprofitable company to go public after the "Kebiao" policy, which will directly boost the domestic production rate of 12-inch silicon wafers to over 20% and enhance the overall competitiveness of China's semiconductor industry [5][6]. Group 1: Company Overview - Xi'an Yiswei's successful listing is a significant milestone, showcasing the collaborative efforts of various stakeholders, with capital playing a crucial role in its development [5][8]. - The company was established in 2016 and initiated its silicon wafer project in 2017, aiming to break the long-standing monopoly of five international giants that control 92% of the market [5][6]. Group 2: Market Context - The demand for 12-inch silicon wafers has surged due to the structural explosion in downstream needs, particularly driven by 3D NAND storage for smartphones and data centers [5][6]. - By 2024, domestic production capacity for 12-inch wafers is expected to reach 2.35 million pieces per month, with Xi'an Yiswei accounting for over 30% of this capacity at 710,000 pieces per month [6]. Group 3: Investment Journey - The investment journey began in early 2019, with the founding team focusing on hard technology and deepening their engagement in the semiconductor industry [7][8]. - Over eight years, the company has raised over 10 billion yuan in financing, with significant investments from various partners, demonstrating a commitment to long-term value in the semiconductor sector [8].

Core Insights - The first three newly registered companies in the Sci-Tech Innovation Board's growth tier officially launched today, just over four months after the China Securities Regulatory Commission (CSRC) announced the establishment of this tier [2] Group 1: Company Developments - Among the first three companies, two are high-tech enterprises in the biopharmaceutical sector, while one is from the semiconductor materials field, all of which are currently unprofitable [2] - Since the beginning of the year, 11 companies have been listed on the Sci-Tech Innovation Board, raising a total of 16.95 billion yuan, representing a year-on-year increase of 54% [2] Group 2: Industry Trends - The Sci-Tech Innovation Board has become the preferred venue for "hard tech" companies to go public in China over the past six years, supporting the listing of 592 companies in high-tech and strategic emerging industries, with a total market capitalization exceeding 9 trillion yuan [2] - Among the 592 listed companies, 383 have been recognized as national-level specialized and innovative "little giant" enterprises [2]

【DT新材料】获悉，近日，LG化学宣布开发出尖端半导体封装核心材料—液态PID(Photo Imageable Dielectric)，正式布局人工智能和高性能半导体市场。 PID作为感光绝缘材料，用在半导体芯片和基板之间建立微电路并形成传输电信号通道，是在先进封装工艺中提高电路精密度、增强半导体性能与可靠性 的核心材料。 随着高性能半导体对于高精密电路的需求不断攀升，PID的重要性日益凸显。LG化学的液态PID具备高分辨率、低温亦可稳定固化、兼具低收缩和低吸收 率的特性，有效提高了工艺稳定性。此外，该产品不含PFAS(全氟及多氟烷基化合物)、NMP和甲苯等物质，更符合环境相关法规要求。 随着集成电路（IC）基板尺寸不断增大、特征尺寸持续缩小，热膨胀差异导致的开裂风险显著增加。传统液态 PID 在大型基板上难以实现双面均匀性， 为此，LG化学还研发出薄膜型 PID，能够解决以下问题： 除此之外，LG 化学正持续扩大先进半导体封装领域关键后端材料的量产与研发规模，涵盖以下品类： 展品范围 材料:高纯气体、高纯石墨、晶种、金属粉、结合剂和黏结剂等 大基板一致性：在大型基板上保持均匀的厚度与图形保真度 高强度与高弹 ...

Group 1 - Three unprofitable companies, He Yuan Bio, Xi'an Yicai, and Biobetter, have been registered as the first batch of companies in the Sci-Tech Innovation Board's growth tier, marking a significant step in capital market support for technological innovation and new productive forces [1][2] - He Yuan Bio is an innovative biopharmaceutical company that has developed key core technologies for recombinant human albumin drugs, offering advantages such as high yield, simple processes, low costs, and scalability [1] - Xi'an Yicai focuses on the research, production, and sales of 12-inch silicon wafers and holds the most authorized domestic and international invention patents in this field in mainland China as of June 2025 [1] Group 2 - Biobetter is concentrated on major diseases such as tumors, autoimmune diseases, and metabolic diseases, with one innovative drug product, BEBT-908, approved for market as of October 2025, and several others in various clinical trial phases [1] - The establishment of the Sci-Tech Innovation Board's growth tier is a response to the development patterns of hard technology and global competition, allowing unprofitable tech companies to access capital markets [2] - The chairman of Xi'an Yicai emphasized that the series of reforms, including the "1+6" policy, has opened doors for companies to leverage capital for accelerating technology transformation and enhancing industrial capabilities [2]